Condition: Atrial Fibrillation (AF) · Stoke · Sponsor: Abbott Medical Devices
The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Arrhythmia Research Group | Phoenix, Arizona, United States | — |
| Arrhythmia Research Group | Jonesboro, Arkansas, United States | — |
| Baptist Medical Center | Jacksonville, Florida, United States | — |
| AdventHealth Orlando | Orlando, Florida, United States | — |
| Northside Hospital | Atlanta, Georgia, United States | — |
| Kansas City Cardiac Arrhythmia Research Foundation | Overland Park, Kansas, United States | — |
| Henry Ford Providence Southfield Hospital | Southfield, Michigan, United States | — |
| Mayo Clinic | Rochester, Minnesota, United States | — |
| CHI Health Creighton University Medical Center-Bergan Mercy | Omaha, Nebraska, United States | — |
| NYU Langone Health | New York, New York, United States | — |
| Mount Sinai Hospital | New York, New York, United States | — |
| Roper Hospital | Charleston, South Carolina, United States | — |
+ 23 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.